Logo Asphalion

HORIZON CALL | OPENING

From ASPHALION, we would like to inform you of the opening of the call: HORIZON-HLTH-2021-DISEASE-04-02: Building a European innovation platform for the repurposing of medicinal products

From ASPHALION, we would like to inform you of the opening of the call: HORIZON-HLTH-2021-DISEASE-04-02: Building a European innovation platform for the repurposing of medicinal products
July 20, 2021

From ASPHALION, we would like to inform you of the opening of the call:

HORIZON-HLTH-2021-DISEASE-04-02: Building a European innovation platform for the repurposing of medicinal products

https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-hlth-2021-disease-04-02

This topic aims at supporting activities under the Horizon EU call “Tackling diseases and reducing disease burden”. In particular, it focuses on innovative repurposing strategies of already approved medicinal products and repositioning of investigational products beyond their original indication.

ASPHALION, as SME company, is actively involved in more than 12 EU granted projects as  regulatory expert partners.

Whether you are planning to apply and you would like to add a regulatory partner to the project or if you are interested in knowing more about ASPHALION and our European granted projects expertise, do not hesitate to contact us  at:

horizon@asphalion.com

Search News & Events

  • Filter by category

Share

Related news and events

In2Sight | 4th annual meeting 3RS congress

At ASPHALION, we are part of the IN2SIGHT consortium, an EU-funded project, and we are delighted to be currently participating in the 4th annual meeting

Course | Regulatory aspects of vaccine development

TRANSVAC2 supported innovation for both prophylactic and therapeutic vaccine development by providing high-quality technical services across four different service platforms: Technology (for process development and GMP production), Immunocorrelates & Systems Biology, Animal models, and support for Clinical Trials. TRANSVAC also offered training courses to provide fundamental and advanced knowledge on a wide-range of vaccine development-related topics.

ASPHALION HIGHLIGHTS Q2 2023

A lot of things have happened during these past three months. We received an award from AEFI as most engaged Company with its employees’ traning;

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting